Year | Author | Study design | Patient subgroup of interest | Major findings |
2020 | Song et al.24 | Retrospective | Stage I, intermediate risk | Minimally invasive surgery group showed higher recurrence rate. |
2021 | Philp et al.25 | Retrospective | Stage I-II, high-intermediate risk | Minimally invasive surgery group showed higher risk of and shorter time to recurrence. |
2021 | Dai et al.26 | Retrospective | All stages, TP53 mutant | Minimally invasive surgery group showed shorter recurrence-free survival. |
2021 | Kim et al.27 | Retrospective | Stage II | Minimally invasive surgery group showed shorter disease-free survival. |